We have detected that your browser blocked our video player. Please enable popups and try again. Thank you. Open Forum II: Key Issues in TB Drug Development 12/12/2006 TB Alliance, Bill and Melinda Gates Foundation, Treatment Action Group, Stop TB Partnership Working Group on New Drugs, London, England     Additional Resources Kaisernetwork.org Coverage of the 37th Union World Conference on Lung Health GlobalHealthReporting.org - Tuberculosis GlobalHealthFacts.org GlobalHealthReporting.org Weekly TB/Malaria Report This two-day forum, hosted by the TB Alliance, Bill and Melinda Gates Foundation, Treatment Action Group and the Stop TB Partnership Working Group on New Drugs, is the second in a series of meetings addressing key issues in TB drug development. This forum includes sessions on key issues in the critical path to TB drug registration, biomarkers for TB drug development, designing pivotal trials, conducting registration trials in high burden countries and developing regimens containing multiple novel agents.   December 12 Sessions   December 13 Sessions EMAIL ALERTS Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.   FAQs How to disable a pop-up blocker How to view a webcast How to listen to a podcast More...   CONTACT US Contact us by email with any comments, problems, suggestions. Call the kaisernetwork.org Help Desk at 202-347-5270. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... About Us     Privacy Policy      Help      Site Map